Clinical Outcomes in Patients With COVID-19 and Hematologic Disease
Authors:
- Olga A. AleshinaOAOlga A. Aleshina
- Kristina ZakurdaevaKZKristina Zakurdaeva
- Anastasia N. VasilevaAVAnastasia N. Vasileva
- Vladimir I. VorobyevVVVladimir I. Vorobyev
- Lev S. ButaevLBLev S. Butaev
- Alena M. SukharevaASAlena M. Sukhareva
- Marina O. PopovaMPMarina O. Popova
- Aleksandr A. SiniaevASAleksandr A. Siniaev
- 14 April 2023
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 23 (8) , 589-598
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Chemotherapy and COVID-19 Outcomes in Patients With CancerJournal of Clinical Oncology, 2020
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort studyThe Lancet Oncology, 2020
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyThe Lancet Haematology, 2020
- Risk factors and outcome of COVID-19 in patients with hematological malignanciesExperimental Hematology & Oncology, 2020
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 2020
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyThe Lancet, 2020
- COVID-19 outcomes in patients with hematologic diseaseBone Marrow Transplantation, 2020
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 OutbreakCancer Discovery, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020